Ozempic Cost Without Insurance: Every Option to Reduce Your Bill

The cost of Ozempic and Wegovy without insurance is one of the biggest barriers to GLP-1 treatment for millions of Americans. This guide covers every option available in 2026 — from manufacturer savings programs to telehealth discounts — to help you access these medications at the lowest possible cost.

Retail Prices Without Insurance (2026)

Medication	Dose	Monthly List Price	What It’s Used For
Ozempic	0.25mg/0.5mg pen	~$935–$970	Type 2 diabetes (also prescribed off-label for weight loss)
Ozempic	1mg pen	~$935–$970	Type 2 diabetes
Ozempic	2mg pen	~$935–$970	Type 2 diabetes
Wegovy	All doses	~$1,349	Obesity / chronic weight management
Rybelsus	3mg, 7mg, 14mg (daily oral)	~$990–$1,050	Type 2 diabetes

Option 1: Novo Nordisk Savings Programs

Novo Nordisk (the manufacturer) offers savings programs that can dramatically reduce out-of-pocket costs for eligible patients:

Program	Eligibility	Savings
Ozempic Savings Card	Commercially insured patients	As low as $25/month for up to 24 months
Wegovy Savings Card	Commercially insured patients	As low as $0/month for eligible patients
Patient Assistance Program (PAP)	Uninsured or underinsured with income below threshold	Free medication

Important: these savings cards typically require commercial insurance — they do NOT work with Medicare or Medicaid. The Patient Assistance Program is the main route for uninsured patients with limited income. Visit NovoNordisk.com or NovoCare.com to apply.

Option 2: GoodRx and Pharmacy Discount Programs

GoodRx and similar discount programs (RxSaver, Blink Health, NeedyMeds) can reduce the cash price at some pharmacies. However, for brand-name GLP-1 medications, the discounts are limited compared to generic drugs. GoodRx prices for Ozempic typically range from $850–$950/month — modest savings from list price, but not transformative. These programs work best when combined with manufacturer coupons for commercially insured patients.

Option 3: Telehealth Platforms with Membership Pricing

Several telehealth platforms offer bundled GLP-1 programs that include the medical consultation, prescription management, and sometimes medication at negotiated rates. Platforms like Ro Body, Hims & Hers, Mochi Health, and Found typically charge $100–$300/month for their membership/service fee plus the cost of medication. Some have pharmacy partnerships that reduce medication costs below retail.

Option 4: Compounded Semaglutide (With Caveats)

During the Ozempic/Wegovy shortage period, compounding pharmacies produced semaglutide at significantly lower cost ($150–$400/month). As of 2026, the legal landscape has changed — semaglutide was removed from the FDA shortage list, restricting most compounding. Compounded tirzepatide may still be available from 503B facilities in some states. Always verify current legal status and use only FDA-registered 503B outsourcing facilities if pursuing compounded options.

Option 5: International Pharmacy Options

In many countries, semaglutide is available at significantly lower prices. Canadian pharmacies, for example, may offer Ozempic at 30–50% below US list price. However, importing prescription medications for personal use exists in a legal grey area in the US. The FDA generally exercises enforcement discretion for personal-use quantities, but there is no guarantee. Quality assurance can also be a concern with international purchases. This option carries risk and should be discussed with your prescriber.

Option 6: Medicare and Medicaid Coverage

Program	Coverage Status (2026)
Medicare Part D (Ozempic for T2D)	Generally covered with Part D plan; cost varies by plan
Medicare Part D (Wegovy for obesity)	Not covered for obesity indication; covered for cardiovascular indication in qualifying patients
Medicaid (Ozempic for T2D)	Coverage varies by state; most states cover
Medicaid (Wegovy for obesity)	Coverage very limited; varies significantly by state

The Inflation Reduction Act and pending Treat and Reduce Obesity Act (TROA) legislation could expand Medicare coverage for obesity medications, but as of early 2026, Wegovy for weight management is not broadly covered by Medicare Part D.

Strategies to Reduce Cost Through Insurance

• Get a formal obesity diagnosis (ICD-10: E66) documented in your medical record
• Document all qualifying comorbidities (hypertension, sleep apnea, T2D, high cholesterol)
• Request prior authorization with thorough medical necessity documentation
• If denied, appeal with a Letter of Medical Necessity from your prescriber
• Ask your prescriber whether Ozempic (for T2D indication) might be covered where Wegovy is not
• Check if your plan covers Wegovy specifically under cardiovascular risk reduction for eligible patients

Frequently Asked Questions

How much does Ozempic cost without insurance per month?
The list price for Ozempic is approximately $935–$970 per month in the US regardless of dose (all doses come in one-pen packs). With Novo Nordisk’s savings card, commercially insured patients may pay as little as $25/month. Uninsured patients without manufacturer assistance pay full list price.

How can I get Wegovy for free or cheap?
Novo Nordisk’s Wegovy savings card reduces costs to as little as $0/month for eligible commercially insured patients. The NovoNordisk Patient Assistance Program provides free medication to qualifying uninsured patients with low income. GoodRx provides modest discounts but not to the same extent as manufacturer programs.

Is there a generic version of Ozempic?
No generic semaglutide exists as of 2026. Novo Nordisk’s semaglutide patents protect against generic competition for years. When generics do eventually enter the market, they will substantially reduce costs — but this is likely a decade away for US patients.

Does GoodRx work for Ozempic?
GoodRx does offer discounted pricing for Ozempic, typically bringing the cash price to $850–$950/month — still very high. GoodRx savings are more meaningful for generic drugs. For Ozempic, manufacturer savings programs (for commercially insured patients) are almost always better than GoodRx.